CCR9 and arthritic joint disease: To conclude, DCs transfected with DNA constructs encoding epitopes of type II collagen, IL-10, and CCR9 promote antigen-specific tolerance, control inflammation, and reduce the severity of experimental arthritis through the induction of T regulatory cells, IL-10, and TGF- β.